Literature DB >> 3896472

Effect of retinoids on the growth, ultrastructure, and cytoskeletal structures of malignant rat osteoblasts.

K W Ng, S A Livesey, F Collier, P R Gummer, T J Martin.   

Abstract

A clonal rat osteogenic sarcoma cell line, UMR 106-06, was used to study the effects of retinoic acid (RA) on its growth and morphology. Retinoic acid caused a reversible, time and dose-dependent inhibition of growth. RA-treated cells were larger, were more adherent to the substratum, and contained fewer mitotic figures. Half-maximal growth inhibition was observed at 10(-8) M. Among the naturally occurring retinoids, RA was clearly the most potent while the arotinoids, Ro 13-7410 and Ro 13-6298, were approximately 50 times more potent than was RA. A similar range of potencies was observed in the cloning efficiencies of the cells in soft agar. Fluorescence microscopy revealed that RA treatment increased the cellular content and organization of F-actin fibers. Ultrastructural changes include decreased chromatin dispersion and increased number of nucleoli per nucleus, decreased rough endoplasmic reticulum, decreased electron density and number of mitochondria, and increased formation of microfilaments and microtubules. These results identify this clonal cell line, which has been extensively characterized as the malignant counterpart of the normal osteoblast, as a target for vitamin A action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896472

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells.

Authors:  H G Schneider; E H Allan; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells.

Authors:  T W McGarvey; S Silberman; B Persky
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

3.  Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid.

Authors:  C Helige; J Smolle; G Zellnig; E Hartmann; R Fink-Puches; H Kerl; H A Tritthart
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

Review 4.  Retinoic acid actions through mammalian nuclear receptors.

Authors:  Pengxiang Huang; Vikas Chandra; Fraydoon Rastinejad
Journal:  Chem Rev       Date:  2013-12-05       Impact factor: 60.622

5.  Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2.

Authors:  S Saneshige; H Mano; K Tezuka; S Kakudo; Y Mori; Y Honda; A Itabashi; T Yamada; K Miyata; Y Hakeda
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

Review 6.  Solid tumor differentiation therapy - is it possible?

Authors:  Filemon Dela Cruz; Igor Matushansky
Journal:  Oncotarget       Date:  2012-05

7.  The endocannabinoid system and retinoic acid signaling combine to influence bone growth.

Authors:  Daniel Fraher; Robert J Mann; Matthew J Dubuisson; Megan K Ellis; Tingsheng Yu; Ken Walder; Alister C Ward; Christoph Winkler; Yann Gibert
Journal:  Mol Cell Endocrinol       Date:  2021-04-09       Impact factor: 4.369

8.  Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy.

Authors:  Ean-Jeong Seo; Thomas Efferth
Journal:  Oncotarget       Date:  2016-03-29

Review 9.  Engaging plasticity: Differentiation therapy in solid tumors.

Authors:  Neta Bar-Hai; Dana Ishay-Ronen
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.